EAM
KRRO icon

Eventide Asset Management’s Korro Bio KRRO Stock Holding History

Eventide Asset Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-117,556
Closed -$4.48M – 243
2024
Q4 		$4.48M Sell
117,556
-273,610
-70% -$14.1M 0.08% 155
2024
Q3 		$13.1M Sell
391,166
-137,989
-26% -$5.81M 0.23% 108
2024
Q2 		$17.9M Sell
529,155
-8,335
-2% -$461K 0.31% 96
2024
Q1 		$48.4M Sell
537,490
-8,835
-2% -$482K 0.76% 49
2023
Q4 		$26.2M Buy
546,325
+474,383
+659% +$15.6M 0.43% 69
2023
Q3 		$10M Buy
+71,942
New +$1.8M 0.18% 121

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Eventide Asset Management's KRRO Position: Q1 2025 in Review

Eventide Asset Management sold out of Korro Bio (KRRO) in Q1 2025, closing a stake of 117,556 shares — an estimated $4.48M sold.

Eventide Asset Management first reported a position in KRRO in Q3 2023 and held it in 6 quarters. The position peaked at $48.4M in Q1 2024. 75 funds tracked by Wall St. Rank hold KRRO as of Q1 2025.

  • Eventide Asset Management reported no remaining Korro Bio position as of Q1 2025 after selling out during the quarter.
  • Eventide Asset Management sold 117,556 Korro Bio shares in Q1 2025, an estimated $4.48M.
  • Eventide Asset Management first reported a position in Korro Bio in Q3 2023 and held it in 6 quarters.
  • Eventide Asset Management's Korro Bio position peaked at $48.4M in Q1 2024.
  • 75 funds tracked by Wall St. Rank held Korro Bio as of Q1 2025.

Based on Eventide Asset Management's 13F filing for Q1 2025, filed 15 May 2025.